Literature DB >> 20837498

BSR and BHPR rheumatoid arthritis guidelines on safety of anti-TNF therapies.

Tina Ding1, Jo Ledingham, Raashid Luqmani, Sarah Westlake, Kimme Hyrich, Mark Lunt, Patrick Kiely, Marwan Bukhari, Rikki Abernethy, Ailsa Bosworth, Andrew Ostor, Kate Gadsby, Frank McKenna, Diana Finney, Josh Dixey, Chris Deighton.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20837498     DOI： 10.1093/rheumatology/keq249a

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  43 in total

1.  Crohn's disease or TB--the perennial question and diagnostic pitfalls.

Authors:  Rudra Krishna Maitra; Tim Bowling; Pradhib Venkatesan; Charles Maxwell-Armstrong
Journal:  BMJ Case Rep       Date:  2012-04-02

Review 2.  Including adverse drug events in economic evaluations of anti-tumour necrosis factor-α drugs for adult rheumatoid arthritis: a systematic review of economic decision analytic models.

Authors:  Eleanor M Heather; Katherine Payne; Mark Harrison; Deborah P M Symmons
Journal:  Pharmacoeconomics       Date:  2014-02       Impact factor: 4.981

Review 3.  New advances in the understanding and treatment of axial spondyloarthritis: from chance to choice.

Authors:  Sayam Dubash; Dennis McGonagle; Helena Marzo-Ortega
Journal:  Ther Adv Chronic Dis       Date:  2017-12-14       Impact factor: 5.091

4.  Screening for latent TB in patients with rheumatic disorders prior to biologic agents in a 'high-risk' TB population: comparison of two interferon gamma release assays.

Authors:  Sunil Melath; Mediola Ismajli; Robin Smith; Ishita Patel; Alan Steuer
Journal:  Rheumatol Int       Date:  2012-12-28       Impact factor: 2.631

5.  Failure of anti-TNF therapy to reactivate previously septic prosthetic joints.

Authors:  Nicholas Manolios; Anthony Burneikis; David Spencer; Graydon Howe
Journal:  BMJ Case Rep       Date:  2013-07-08

6.  Patterns and associated risk of perioperative use of anti-tumor necrosis factor in patients with rheumatoid arthritis undergoing total knee replacement.

Authors:  Beverly K Johnson; Susan M Goodman; Michael M Alexiades; Mark P Figgie; Ryan T Demmer; Lisa A Mandl
Journal:  J Rheumatol       Date:  2013-04-01       Impact factor: 4.666

Review 7.  Should anti-TNF therapy be discontinued in rheumatoid arthritis patients undergoing elective orthopaedic surgery? A systematic review of the evidence.

Authors:  Leslie Goh; Teresa Jewell; Catherine Laversuch; Ash Samanta
Journal:  Rheumatol Int       Date:  2011-07-29       Impact factor: 2.631

Review 8.  Comparison of national clinical practice guidelines and recommendations on vaccination of adult patients with autoimmune rheumatic diseases.

Authors:  Despoina Papadopoulou; Nikolaos V Sipsas
Journal:  Rheumatol Int       Date:  2013-12-10       Impact factor: 2.631

9.  Biologic therapy for inflammatory arthritis and latent tuberculosis: real world experience from a high prevalence area in the United Kingdom.

Authors:  Muhammad K Nisar; Aneesa Rafiq; Andrew J K Östör
Journal:  Clin Rheumatol       Date:  2015-10-24       Impact factor: 2.980

Review 10.  Perioperative management of the patient with rheumatoid arthritis.

Authors:  Megan L Krause; Eric L Matteson
Journal:  World J Orthop       Date:  2014-07-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.